Loading…
Loading…
Bio-Rad Laboratories Inc - Class A
NYSE · Stock Profile · Market Cap $7.23B
Current Price
$267.99
-0.55%GoodMoat Value
$343.45
28.2% undervaluedFree cash flow has been growing at 37.5% annually.
Forward estimates use 37.5% FCF growth (CAGR)
Net Debt: 855M
639M
FY24
650M
FY24
2.6B
FY24
585M
FY25
652M
FY25
653M
FY25
2.6B
FY25
—
FY24
653M
FY24
—
FY24
64M
FY25
318M
FY25
—
FY25
760M
FY25
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
California, USA
Free cash flow has been growing at 37.5% annually.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
California, USA